Carvana ($CVNA): When to Buy More During the Cancer Surgery Formula (Update #4)

What other investors were looking for before buying significantly more of the companies that followed this model.

Stock Price as of 6.29.2023: ~$25.74 / Share

One of the single thoughts I kept coming back to throughout these last 8+ months was the “Cancer Surgery Formula”.

Given some of the new information that has come out from Carvana since this original post, I wanted to provide some updates on how CVNA is tracking this model, and what other investors were looking for before buying more with their companies that followed the Cancer Surgery Formula.

This was a large reason for me significantly increasing my CVNA share count since that original post.

(#4) 6.29.2023: When to Buy More During the Cancer Surgery Formula

When I last discussed the “Cancer Surgery Formula” and how it could relate to Carvana back on 10/31/2022, it was just a little after the 22Q2 earnings and before 22Q3 earnings came out, with CVNA working on their cost cutting and cost efficiency initiatives.

While it seemed likely, at that time it was still a little too soon to know if CVNA would repeat the actions and success of other companies and investments that went through this formula (many of these other investments were discussed in the original post).

And although CVNA’s stock has increased quite a bit from the lows of <$4 to now >$25, has CVNA actually been following along with this formula? Is it tracking what other successful companies / investments experienced that followed this model, which could lead to even higher prices than today? What should we be looking for? What did others look for before buying more?